Carlos E. Ibañez

1.7k citations

37 papers · 1.4k indexed · h-index 20

Impact in

Virology top 5%
- HIV Research and Treatment
Genetics top 5%
- Virus-based gene therapy research

Papers in

Virology 5
- HIV Research and Treatment 5
Genetics 24
- Virus-based gene therapy research 24
- Glioma Diagnosis and Treatment 7

Co-authors: Joseph S. Lipsick Peter Ghazal Jay A. Nelson Rachel Schrier Douglas J. Jolly Harry E. Gruber Noriyuki Kasahara Joan M. Robbins
Journals: Journal of Virology (8 papers)Molecular Therapy (5 papers)Molecular and Cellular Biology (4 papers)Human Gene Therapy (3 papers)Neuro-Oncology (3 papers)
Partner nations: United States Austria Russia

In The Last Decade

Carlos E. Ibañez

35 papers receiving 1.3k citations

Peers

Countries citing papers authored by Carlos E. Ibañez

Since Specialization

Citations

This map shows the geographic impact of Carlos E. Ibañez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos E. Ibañez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos E. Ibañez more than expected).

Fields of papers citing papers by Carlos E. Ibañez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos E. Ibañez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos E. Ibañez. The network helps show where Carlos E. Ibañez may publish in the future.

Co-authors

The 25 scholars most cited alongside Carlos E. Ibañez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlos E. Ibañez Line = papers co-authored together Carlos E. Ibañez links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models Molecular Therapy — Oncolytics ·Kader Yagiz, Maria E. Rodriguez-Aguirre, Fernando Lopez Espinoza, Tiffany T. Montellano, Daniel Mendoza, Leah Mitchell, Carlos E. Ibañez, Noriyuki Kasahara, Harry E. Gruber, Douglas J. Jolly, Joan M. Robbins	2017	22
2	Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene Human Gene Therapy Methods ·Amy Lin, Yanzheng Liu, Cynthia Burrascano, Kathrina Cunanan, Christopher R. Logg, Joan M. Robbins, Noriyuki Kasahara, Harry E. Gruber, Carlos E. Ibañez, Douglas J. Jolly	2016	3
3	Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models Neuro-Oncology ·Kader Yagiz, Tiffany Huang, Fernando Lopez Espinoza, Daniel Mendoza, Carlos E. Ibañez, Harry E. Gruber, Douglas J. Jolly, Joan M. Robbins	2016	15
4	Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types Human Gene Therapy Methods ·Chris Twitty, Oscar R. Diago, Daniel J. Hogan, Cindy Burrascano, Carlos E. Ibañez, Douglas J. Jolly, Derek Ostertag	2015	27
5	Intravenous Administration of Retroviral Replicating Vector, Toca 511, Demonstrates Therapeutic Efficacy in Orthotopic Immune-Competent Mouse Glioma Model Human Gene Therapy ·Tiffany Huang, Shraddha Parab, Ryan Burnett, Oscar R. Diago, Derek Ostertag, Florence M. Hofman, Fernando Lopez Espinoza, Bryan Martin, Carlos E. Ibañez, Noriyuki Kasahara, Harry E. Gruber, Daniel Pertschuk, Douglas J. Jolly, Joan M. Robbins	2014	49
6	Abstract 708: Toca 511 gene therapy in combination with 5-fluorocytosine for intratumoral production of 5-fluorouracil in a colon cancer metastasis model Cancer Research ·Maria E. Rodriguez-Aguirre, Fernando Lopez Espinoza, Bryan Martin, Kader Yadiz, Tiffany Huang, Carlos E. Ibañez, Derek Ostertag, Noriyuki Kasahara, Harry E. Gruber, Douglas J. Jolly, Joan M. Robbins	2014	1
7	Blockade of Type I Interferon (IFN) Production by Retroviral Replicating Vectors and Reduced Tumor Cell Responses to IFN Likely Contribute To Tumor Selectivity Journal of Virology ·Amy Lin, Cindy Burrascano, Pär L. Pettersson, Carlos E. Ibañez, Harry E. Gruber, Douglas J. Jolly	2014	20
8	Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model Cancer Gene Therapy ·Dong Yin, You Zhai, Harry E. Gruber, Carlos E. Ibañez, Joan M. Robbins, Adrian P. Kells, Noriyuki Kasahara, John Forsayeth, Douglas J. Jolly, Krys S. Bankiewicz	2013	21
9	Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model Cancer Gene Therapy ·Tiffany Huang, Juraj Hlavatý, Derek Ostertag, Fernando Lopez Espinoza, B. Martin, Helga Petznek, Maria E. Rodriguez-Aguirre, Carlos E. Ibañez, Noriyuki Kasahara, Walter H. Günzburg, Harry E. Gruber, Daniel Pertschuk, Douglas J. Jolly, Joan M. Robbins	2013	45
10	Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression Molecular Therapy ·Omar D. Perez, Christopher R. Logg, Kei Hiraoka, Oscar R. Diago, Ryan Burnett, Akihito Inagaki, Dawn Jolson, Karin Amundson, Taylor Buckley, Dan Lohse, Amy Lin, Cindy Burrascano, Carlos E. Ibañez, Noriyuki Kasahara, Harry E. Gruber, Douglas J. Jolly	2012	112
11	Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector Neuro-Oncology ·Derek Ostertag, Karin Amundson, F. Lopez Espinoza, B. Martin, Taylor Buckley, Ana Paula da Silva, A. Lin, David T. Valenta, O. D. Perez, Carlos E. Ibañez, C.-I. Chen, Pär L. Pettersson, Ryan Burnett, V. Daublebsky, Juraj Hlavatý, Walter H. Günzburg, Noriyuki Kasahara, Harry E. Gruber, Douglas J. Jolly, Joan M. Robbins	2011	110
12	Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production and Clinical Application: Improved Safety and High Titer Molecular Therapy ·Philip L. Sheridan, Mordechai Bodner, Andrea Lynn, Trung K. Phuong, Nicholas J. DePolo, Daniel J. de la Vega, Joanne O'Dea, Kathy Nguyen, James E. McCormack, David A. Driver, Kay Townsend, Carlos E. Ibañez, Nancy Sajjadi, Judith S. Greengard, Margaret Moore, James Respess, Stephen M. W. Chang, Thomas W. Dubensky, Douglas J. Jolly, Sybille L. Sauter	2000	49
13	Generation of a Systemic Antitumor Response with Regional Intratumoral Injections of Interferon γ Retroviral Vector Human Gene Therapy ·Linda M. Karavodin, Joan Robbins, Chong Ae Kim, David S. Hsu, Carlos E. Ibañez, Steven J. Mento, Doug J. Jolly, T. Fong	1998	20
14	Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line Biology of Blood and Marrow Transplantation ·Gerhard Bauer, Sybille L. Sauter, Carlos E. Ibañez, Chantelle Rice, Penelope Valdez, Doug J. Jolly, Donald B. Kohn	1998	5
15	Establishment of Parameters for Optimal Transduction Efficiency and Antitumor Effects with Purified High-Titer HSV-TK Retroviral Vector in Established Solid Tumors Human Gene Therapy ·W. Russell Smiley, Boris Laubert, BRADLEY D. HOWARD, Carlos E. Ibañez, Timothy Fong, William S. Summers, Francis Burrows	1997	22
16	Human cytomegalovirus productively infects primary differentiated macrophages Journal of Virology ·Carlos E. Ibañez, Rachel Schrier, Peter Ghazal, Cheryl Wiley, Jay A. Nelson	1991	267
17	trans Activation of Gene Expression by v-myb Molecular and Cellular Biology ·Carlos E. Ibañez, Joseph S. Lipsick	1990	38
18	Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation Journal of Virology ·Carlos E. Ibañez, Joseph S. Lipsick	1988	58
19	env-encoded residues are not required for transformation by p48v-myb Journal of Virology ·Joseph S. Lipsick, Carlos E. Ibañez	1987	19
20	Expression of molecular clones of v-myb in avian and mammalian cells independently of transformation Journal of Virology ·Joseph S. Lipsick, Carlos E. Ibañez, M A Baluda	1986	32

About Carlos E. Ibañez

Carlos E. Ibañez is a scholar working on Virology, Genetics, Genetics, Biotechnology and Applied Microbiology and Biotechnology, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (24 papers), CRISPR and Genetic Engineering (10 papers), RNA Interference and Gene Delivery (8 papers), Glioma Diagnosis and Treatment (7 papers), HIV Research and Treatment (5 papers), Cancer Research and Treatments (4 papers), CAR-T cell therapy research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). The work is most often cited by research in Virology (143 citations), Genetics (516 citations), Immunology (379 citations), Oncology (333 citations) and Genetics (123 citations). Carlos E. Ibañez has collaborated with scholars based in United States, Austria and Russia. Frequent co-authors include Joseph S. Lipsick, Peter Ghazal, Jay A. Nelson, Rachel Schrier, Douglas J. Jolly, Harry E. Gruber, Noriyuki Kasahara, Joan M. Robbins, Derek Ostertag and Arnold Garcia. Their work appears in journals such as Journal of Virology, Molecular Therapy, Molecular and Cellular Biology, Human Gene Therapy and Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact